Dialogues in clinical neuroscience

Psychedelic drugs and their potential role in modern psychiatry

Updated

Abstract

Preliminary data suggest that psilocybin and may be effective in treating several psychiatric conditions.

  • drugs like psilocybin and MDMA have been reconsidered in psychiatric research after a long period of prohibition.
  • Research indicates promising results for psilocybin in treating anxiety, depression, and alcoholism.
  • MDMA shows potential in treating post-traumatic stress disorder (PTSD) and alcoholism.
  • The European Medicines Agency has approved psilocybin for a phase 3 study in treatment-resistant depression.
  • The Food and Drug Administration has approved MDMA for a phase 3 study in PTSD.
  • Positive outcomes from these trials could lead to clinical approval of these substances.

Simplified

Full Text

We can’t show the full text here under this license.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free